CYP2J2 and hepatocellular carcinoma: However, expression of another homologous gene, CYP2J2, was not significantly associated with survival time in patients with HCC in the TCGA data (Supplementary Figures 10), although CYP2J2 expression has been reported to be associated with tumor progression57,58.